Though we were able to find already reported gender-specific differences in the methylation profile of the ALPPL2 target, we did not detect any significant difference in any of selected targets in relation to schizophrenia, suggesting that at least for these genomic sites, smoking methylation signatures were independent of a schizophrenia diagnosis. This evidence concerns the gene ALPG and schizophrenia.